Subcutaneous Implantable Cardioverter-defibrillator (S-ICD) Eligibility Over Time in Arrhythmogenic Cardiomyopathy

by palligoelme@gmail.com | Oct 5, 2026 | Clinical Trials

​ Conditions: Arrhythmogenic Cardiomyopathy Interventions: Diagnostic Test: Subcutaneous ICD ECG screening Sponsors: University of Sao Paulo Recruiting Conditions: Arrhythmogenic Cardiomyopathy Interventions: Diagnostic Test: Subcutaneous ICD ECG screening Sponsors:...

SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

by palligoelme@gmail.com | Oct 5, 2026 | Clinical Trials

​ Conditions: Locally Advanced /Metastatic Solid Tumors; Locally Advanced / Metastatic Solid Tumors; Metastatic Solid Cancers; Non Small Cell Lung Cancer; Lung Cancer; Melanoma; Ovarian; NSCLC Interventions: Drug: SI-B036 Sponsors: SystImmune Inc. Not yet...

Initial Safety and Preliminary Efficacy of the Novelrad Vascular Closure System (NVCS)

by palligoelme@gmail.com | Oct 5, 2026 | Clinical Trials

​ Conditions: Vascular Closure Device; Femoral Arteriotomy Closure; Femoral Access Site Closure Interventions: Device: Novelrad Vascular Closure System (NVCS) Sponsors: Novelrad Ltd. Completed Conditions: Vascular Closure Device; Femoral Arteriotomy Closure; Femoral...

Cardiovascular Safety of Atomoxetine in Children With ADHD

by palligoelme@gmail.com | Oct 5, 2026 | Clinical Trials

​ Conditions: Attention Deficit Hyperactivity Disorder Sponsors: Assiut University Not yet recruiting Conditions: Attention Deficit Hyperactivity Disorder Sponsors: Assiut University Not yet recruiting 

Exercise Phenotyping Prior to Chemotherapy in Newly Diagnosed Multiple Myeloma (MM-Exercise)

by palligoelme@gmail.com | Oct 5, 2026 | Clinical Trials

​ Conditions: Exercise Behavior; Multiple Myeloma Sponsors: Technical University of Munich Recruiting Conditions: Exercise Behavior; Multiple Myeloma Sponsors: Technical University of Munich Recruiting